ARVNArvinas, Inc.
What is the market doing?
In a downtrend (−25% vs 200-day). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
In a downtrend, below its 50- and 200-day averages. Price is −25% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ARVN is trading
Arvinas, Inc. is −19% over the past year while the S&P 500 is +18%: 37 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −25%
vs 200-day average · a clear downtrend
- RSI (14)
- 32
RSI (14) · neutral
- Below its 52-week high
- 46%
Below its 52-week high
Details›
- Last close2026-10-08
- $7.52
- 1 monthS&P 500 +1.6%
- −14%
- 1 yearS&P 500 +18%
- −19%
- 5 yearsS&P 500 +86%
- −91%
- vs 50-day average$8.56
- −12%
- 52-week high
- $13.83
- 52-week low
- $6.98
- Annualised volatility
- 71%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$452K
| Year | Return |
|---|---|
| 2026 (year to date) | −37% |
| 2025 | −38% |
| 2024 | −53% |
| 2023 | +20% |
| 2022 | −58% |
| 2021 | −3.3% |
| 2020 | +107% |
| 2019 | +220% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 4 of 8 | +3.8% |
| Feb | 8 | 4 of 8 | +0.86% |
| Mar | 8 | 1 of 8 | −19% |
| Apr | 8 | 4 of 8 | +7.6% |
| May | 8 | 3 of 8 | −13% |
| Jun | 8 | 6 of 8 | +0.20% |
| Jul | 8 | 5 of 8 | +9.2% |
| Aug | 8 | 3 of 8 | −3.4% |
| Sep | 8 | 2 of 8 | −8.5% |
| Oct | 9 | 4 of 9 | +0.40% |
| Nov | 8 | 6 of 8 | +17% |
| Dec | 8 | 4 of 8 | +35% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
The closest names by size in the same industry